Education
About Us
Working with TipRanks
Follow Us
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
RESEARCH TOOLSreports
1652 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.24 - HK$1.19
Previous CloseN/A
Volume70.00K
Average Volume (3M)151.40K
Market Cap
HK$235.27M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Aug 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 07, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding739,301,000
10 Day Avg. Volume251,700
30 Day Avg. Volume151,400
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Fusen Pharmaceutical Co., Ltd. News
1652 FAQ
What was Fusen Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Fusen Pharmaceutical Co., Ltd. lowest stock price was HK$0.23 and its highest was HK$1.19 in the past 12 months.
What is Fusen Pharmaceutical Co., Ltd.’s market cap?
Fusen Pharmaceutical Co., Ltd.’s market cap is HK$235.27M.
When is Fusen Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Fusen Pharmaceutical Co., Ltd.’s upcoming earnings report date is Aug 27, 2025 which is in 25 days.
How were Fusen Pharmaceutical Co., Ltd.’s earnings last quarter?
Fusen Pharmaceutical Co., Ltd. released its earnings results on Mar 31, 2025. The company reported -HK$0.223 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.223.
Is Fusen Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Fusen Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Fusen Pharmaceutical Co., Ltd. pay dividends?
Fusen Pharmaceutical Co., Ltd. pays a Notavailable dividend of HK$0.004 which represents an annual dividend yield of N/A. See more information on Fusen Pharmaceutical Co., Ltd. dividends here
What is Fusen Pharmaceutical Co., Ltd.’s EPS estimate?
Fusen Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fusen Pharmaceutical Co., Ltd. have?
Fusen Pharmaceutical Co., Ltd. has 739,301,000 shares outstanding.
What happened to Fusen Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Fusen Pharmaceutical Co., Ltd. reported an EPS of -HK$0.223 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of Fusen Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in HK:1652
Fusen Pharmaceutical Co., Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.34%
12-Months-Change
Fundamentals
Return on Equity
-40.39%
Trailing 12-Months
Asset Growth
-10.94%
Trailing 12-Months
Company Description
Fusen Pharmaceutical Co., Ltd.
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
Technical Analysis
Huakang Biomedical Holdings Company Limited
―
Zhongzhi Pharmaceutical Holdings Limited
―
PuraPharm Corp. Ltd.
―
China NT Pharma Group Co., Ltd.
―